Effect of intravitreal dexamethasone solution on the reduction of macular thickness in pseudophakic diabetic patients in a public hospital in Brazil: a randomized clinical trial
Andre Luis A Fonseca, Heitor Panetta, Mauricio A Nascimento, Rodrigo Pessoa C Lira, Carlos Eduardo L ArietaDepartment of Ophthalmology, State University of Campinas, Campinas, São Paulo, BrazilPurpose: To determine the effect of short-term 4 mg/mL dexamethasone solution treatment in diabe...
Guardado en:
Autores principales: | Fonseca ALA, Panetta H, Nascimento MA, Lira RPC, Arieta CEL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80013f68f9474151855e17ba103e7731 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
por: Javier Obis, et al.
Publicado: (2021) -
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski A, et al.
Publicado: (2016) -
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas BJ, et al.
Publicado: (2016) -
Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
por: Zola M, et al.
Publicado: (2017) -
Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
por: Taylor K, et al.
Publicado: (2020)